Skip to Content
October 06, 2024 Clear | 47°F
The 193rd General Court of the Commonwealth of Massachusetts

Bill S.2520 193rd (Current)

An Act relative to pharmaceutical access, costs and transparency

Bill Information

Sponsor:
Senate Committee on Bills in the Third Reading

Bill History

Displaying 19 actions for Bill S.2520
Date Branch Action
11/15/2023 Senate Reported from the committee on Senate Bills in the Third Reading
11/15/2023 Senate New draft of S2499
11/15/2023 Senate Passed to be engrossed -see Roll Call #99 (Yeas 39 to Nays 0)
11/20/2023 House Read; and referred to the committee on House Ways and Means
7/22/2024 House Committee recommended ought to pass with an amendment, substituting the text of an amendment, see H4891
7/22/2024 House Referred to the committee on House Steering, Policy and Scheduling with the amendment pending
7/24/2024 House Committee reported that the matter be placed in the Orders of the Day for the next sitting with the amendment pending
7/24/2024 House Read second
7/24/2024 House Amendment (as recommended by the committee on House Ways and Means) adopted
7/24/2024 House Ordered to the third reading
7/24/2024 House Rules suspended
7/24/2024 House Read third
7/24/2024 House Amended by substitution of a new text (see H4910)
7/24/2024 House Passed to be engrossed - 158 YEAS to 0 NAYS (See YEA and NAY No. 142 )
7/25/2024 Senate Rules suspended
7/25/2024 Senate Senate NON-concurred in the House amendment
7/25/2024 Senate Committee on conference (Friedman-Cronin-Tarr), appointed
7/25/2024 House House insisted on its amendment
7/25/2024 House Committee of conference appointed - (Lawn-F. Moran-Barrows), in concurrence

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.